181 related articles for article (PubMed ID: 36181326)
1. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
[TBL] [Abstract][Full Text] [Related]
2. The concept of synthetic lethality in the context of anticancer therapy.
Kaelin WG
Nat Rev Cancer; 2005 Sep; 5(9):689-98. PubMed ID: 16110319
[TBL] [Abstract][Full Text] [Related]
3. [Synthetic lethality as a functional tool in basic research and in anticancer therapy].
Toma M; Skorski T; Sliwiński T
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1091-103. PubMed ID: 25228518
[TBL] [Abstract][Full Text] [Related]
4. A lethal combination for cancer cells: synthetic lethality screenings for drug discovery.
Ferrari E; Lucca C; Foiani M
Eur J Cancer; 2010 Nov; 46(16):2889-95. PubMed ID: 20724143
[TBL] [Abstract][Full Text] [Related]
5. The role of drug-metabolizing enzymes in synthetic lethality of cancer.
Zeng Z; Zheng W; Hou P
Pharmacol Ther; 2022 Dec; 240():108219. PubMed ID: 35636517
[TBL] [Abstract][Full Text] [Related]
6. Malignancy of Cancers and Synthetic Lethal Interactions Associated With Mutations of Cancer Driver Genes.
Wang X; Zhang Y; Han ZG; He KY
Medicine (Baltimore); 2016 Feb; 95(8):e2697. PubMed ID: 26937901
[TBL] [Abstract][Full Text] [Related]
7. Harnessing synthetic lethal interactions in anticancer drug discovery.
Chan DA; Giaccia AJ
Nat Rev Drug Discov; 2011 May; 10(5):351-64. PubMed ID: 21532565
[TBL] [Abstract][Full Text] [Related]
8. Syn-lethality: an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies.
Li XJ; Mishra SK; Wu M; Zhang F; Zheng J
Biomed Res Int; 2014; 2014():196034. PubMed ID: 24864230
[TBL] [Abstract][Full Text] [Related]
9. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis.
Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T
Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468
[TBL] [Abstract][Full Text] [Related]
10. Development of synthetic lethality anticancer therapeutics.
Fang B
J Med Chem; 2014 Oct; 57(19):7859-73. PubMed ID: 24893124
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Lethal Interactions in Cancer Therapy.
Geng X; Wang X; Zhu D; Ying S
Curr Cancer Drug Targets; 2017; 17(4):304-310. PubMed ID: 27113746
[TBL] [Abstract][Full Text] [Related]
12. Predicting synthetic lethal interactions in human cancers using graph regularized self-representative matrix factorization.
Huang J; Wu M; Lu F; Ou-Yang L; Zhu Z
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):657. PubMed ID: 31870274
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer cells by synthetic lethality: autophagy and VHL in cancer therapeutics.
Chan DA; Giaccia AJ
Cell Cycle; 2008 Oct; 7(19):2987-90. PubMed ID: 18818511
[TBL] [Abstract][Full Text] [Related]
14. Synthetic lethality as an engine for cancer drug target discovery.
Huang A; Garraway LA; Ashworth A; Weber B
Nat Rev Drug Discov; 2020 Jan; 19(1):23-38. PubMed ID: 31712683
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential synthetic lethal genes to p53 using a computational biology approach.
Wang X; Simon R
BMC Med Genomics; 2013 Sep; 6():30. PubMed ID: 24025726
[TBL] [Abstract][Full Text] [Related]
16. Synthetic lethal interactions for the development of cancer therapeutics: biological and methodological advancements.
Mizuarai S; Kotani H
Hum Genet; 2010 Dec; 128(6):567-75. PubMed ID: 20976469
[TBL] [Abstract][Full Text] [Related]
17. Application of the concept synthetic lethality toward anticancer therapy: a promise fulfilled?
Canaani D
Cancer Lett; 2014 Sep; 352(1):59-65. PubMed ID: 23962561
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
Weng S; Ruan H
FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
[TBL] [Abstract][Full Text] [Related]
19. Synthetic lethal interaction between oxidative stress response and DNA damage repair in the budding yeast and its application to targeted anticancer therapy.
Choi JE; Chung WH
J Microbiol; 2019 Jan; 57(1):9-17. PubMed ID: 30594981
[TBL] [Abstract][Full Text] [Related]
20. [Synthetic lethal genes to mutant p53].
Liu TY; Guo HQ; Zhu MY; Huang YZ; Jia ST; Luo Y; Zhang JH
Yi Chuan; 2015 Apr; 37(4):321-326. PubMed ID: 25881697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
